These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Ocular motor dysfunction and ptosis in ocular myasthenia gravis: effects of treatment. Kupersmith MJ; Ying G Br J Ophthalmol; 2005 Oct; 89(10):1330-4. PubMed ID: 16170126 [TBL] [Abstract][Full Text] [Related]
24. Long-term administration of corticosteroids in myasthenia gravis. Mann JD; Johns TR; Campa JF Neurology; 1976 Aug; 26(8):729-40. PubMed ID: 821005 [TBL] [Abstract][Full Text] [Related]
25. The effect of prednisone on the progression from ocular to generalized myasthenia gravis. Monsul NT; Patwa HS; Knorr AM; Lesser RL; Goldstein JM J Neurol Sci; 2004 Feb; 217(2):131-3. PubMed ID: 14706214 [TBL] [Abstract][Full Text] [Related]
26. [Usefulness of plasmapheresis before thymectomy in the management of myasthenia gravis]. Iváñez V; Díez-Tejedor E; Lara M; Barreiro P Neurologia; 1994; 9(7):277-81. PubMed ID: 7946422 [TBL] [Abstract][Full Text] [Related]
27. Delayed remission after thymectomy for myasthenia gravis of the purely ocular type. Nakamura H; Taniguchi Y; Suzuki Y; Tanaka Y; Ishiguro K; Fukuda M; Hara H; Mori T J Thorac Cardiovasc Surg; 1996 Aug; 112(2):371-5. PubMed ID: 8751505 [TBL] [Abstract][Full Text] [Related]
34. Thymectomy in the treatment of myasthenia gravis. Gutmann L; Warden HE; Wertheimer RI; Riggs JE W V Med J; 1985 Feb; 81(2):29-31. PubMed ID: 3856372 [No Abstract] [Full Text] [Related]
35. Myasthenia gravis in children: long-term follow-up. Rodriguez M; Gomez MR; Howard FM; Taylor WF Ann Neurol; 1983 May; 13(5):504-10. PubMed ID: 6870202 [TBL] [Abstract][Full Text] [Related]
36. Influence of ectopic thymic tissue on clinical outcome following extended thymectomy in generalized seropositive nonthymomatous myasthenia gravis. Ponseti JM; Gamez J; Vilallonga R; Ruiz C; Azem J; López-Cano M; Armengol M Eur J Cardiothorac Surg; 2008 Nov; 34(5):1062-7. PubMed ID: 18760934 [TBL] [Abstract][Full Text] [Related]
37. Thymectomy as primary therapy in myasthenia gravis. Olanow CW; Wechsler AS; Sirotkin-Roses M; Stajich J; Roses AD Ann N Y Acad Sci; 1987; 505():595-606. PubMed ID: 3479941 [No Abstract] [Full Text] [Related]
38. Plasmapheresis and immunosuppressive drug therapy in myasthenia gravis. Dau PC; Lindstrom JM; Cassel CK; Denys EH; Shev EE; Spitler LE N Engl J Med; 1977 Nov; 297(21):1134-40. PubMed ID: 917042 [TBL] [Abstract][Full Text] [Related]
39. [Misdiagnosis of mitochondrial myopathies: a study of 12 thymectomized patients]. Ben Yaou R; Laforêt P; Bécane HM; Jardel C; Sternberg D; Lombès A; Eymard B Rev Neurol (Paris); 2006 Mar; 162(3):339-46. PubMed ID: 16585889 [TBL] [Abstract][Full Text] [Related]
40. The long term experience of thymectomy for myasthenia gravis. Scadding GK; Havard CW; Lange MJ; Domb I J Neurol Neurosurg Psychiatry; 1985 May; 48(5):401-6. PubMed ID: 3998750 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]